Diabetes Mellitus Type 2 Perspective

• Tirzepatide: 'Exciting' and Promising in Lowering A1c   Tirzepatide is the newest player in the quest for lowering A1c in people with type 2 diabetes. Dr Anne Peters describes the novel agent -- what it can do for patients now and in the future.
  Medscape Diabetes & Endocrinology, May 23, 2022
• Episode 4: Better Ways to Sustain Weight Loss in Type 2 Diabetes   Patients with type 2 diabetes and obesity have more options today than ever before. Join host Dr Silvio Inzucchi and obesity expert Dr Ania Jastreboff as they discuss ways to support weight loss.
  Medscape, May 18, 2022
• Does COVID-19 Raise the Risk for Diabetes?   Is COVID-19 responsible for new-onset diabetes? Or are COVID infections bringing to light previously undiagnosed cases? Dr Anne Peters reviews recent studies around COVID and diabetes.
  Medscape Diabetes & Endocrinology, May 17, 2022
• AACE 2022 Read clinically focused news coverage of key developments from AACE 2022
  Medscape Diabetes & Endocrinology, May 13, 2022
• Diabetes & Kidney Disease: A Heart in Jeopardy: Helping a Hero   An Air Force veteran with CKD shares his experience managing multiple chronic conditions and participating in research trials.
  Medscape TV, May 09, 2022
• Therapies 'Not Used Enough' in Patients With T2D and CVD Risk   Dr Anne Peters discusses a paper demonstrating the low use of appropriate therapies in patients with type 2 diabetes and established cardiovascular risk.
  Medscape Diabetes & Endocrinology, May 04, 2022
• Key Points From the New Heart Failure Guidelines   Dr Ileana Piña discusses the 2022 AHA/ACC/HFSA heart failure guidelines and how they compare with the European guidelines and recent data on heart failure.
  theheart.org on Medscape, May 04, 2022
• Beyond Glucose: Reducing CVD in Patients With Diabetes: Integrative Approach   Cardiologists discuss the multiple evidence-based treatment modalities, such as acupuncture, included in the UC Irvine preventive cardiology program.
  Medscape TV, April 26, 2022
• Diabetes and Heart Disease Highlights From ACC 2022   Dr Martha Gulati shares key reports from ACC 2022, including updates on SGLT2 inhibitors from the SCORED trial, chronic hypertension in pregnancy, and heart-healthy diet education in supermarkets.
  Medscape, April 25, 2022
• Top Abstracts in Atherosclerosis and Lipid Management From ACC 2022   Key data on atherosclerosis and lipids from ACC 2022 include PACMAN-AMI results with alirocumab, a new look at waist circumference in REDUCE-IT, and a subgroup analysis of SCORED with sotagliflozin.
  Medscape, April 25, 2022
• Type 2 Diabetes With ASCVD   Experts in endocrinology and cardiology evaluate a patient with troubling risk factors for cardiovascular disease and discuss the potential benefits of new therapies and lifestyle modifications.
  Medscape, April 19, 2022
• Battling Obesity by Breaking Down Barriers Two primary care physicians detail their experiences in treating those with obesity through a community-based dedicated weight clinic after receiving their obesity medicine certification.
  Medscape Diabetes & Endocrinology, April 19, 2022
• Episode 3: How to Reduce Renal Risk in Type 2 Diabetes   Want to prevent kidney disease progression in patients with type 2 diabetes? Join host Dr Silvio Inzucchi and nephrologist Dr David Cherney as they unpack the how and why behind current recommendations.
  Medscape, April 13, 2022
• The Burden of Undiagnosed Diabetes Dr Jain reviews the International Diabetes Federation Atlas, predicting an 'alarming' number of people living with undiagnosed diabetes — particularly youth.
  Medscape Diabetes & Endocrinology, April 12, 2022
• Eric Topol: 'I Still Have My Guard Up'   Why we should be shifting into high gear on treatments for long COVID and a pan-beta-coronavirus vaccine.
  Medscape, April 08, 2022
• Is Saturated Fat or Carbohydrates Worse for the Liver? Dr. Caroline Apovian discusses whether fat or carbohydrate overfeeding is more likely to lead to the development of nonalcoholic fatty liver disease.
  Medscape Diabetes & Endocrinology, April 07, 2022
• Apr 1 2022 This Week in Cardiology   Coronary CTA, semaglutide, coronary artery calcium, exercise, and an ACC and EHRA preview are the topics discussed by John Mandrola, MD, in this week’s podcast.
  theheart.org on Medscape, April 01, 2022
• Chronic Heart Failure With Reduced Ejection Fraction   A 71 y.o. woman has chronic heart failure with reduced ejection fraction. Experts review her case history, discuss treatment options, and set care priorities in advance of her first post-discharge visit.
  Medscape, March 29, 2022
• HFpEF: New Treatments Provide 'Hope'   Drs Clyde Yancy and Ravi Patel discuss contemporary treatment approaches for heart failure with preserved ejection fraction.
  American College of Cardiology & Medscape , March 28, 2022
• Her Burning Feet: What to Try Next for Peripheral Neuropathy Dr Charles Vega's patient has persistent, painful neuropathy of her feet. After several treatment failures, what's left?
  Medscape Family Medicine, March 24, 2022